Search bioRxiv⌕ Search

Biology subjects

Dassama, L. M. K.

Publications and source records attributed to Dassama, L. M. K..

3 recordsLinked to original sources

Rapid proteome-wide prediction of lipid-interacting proteins through ligand-guided structural genomics

Lipids are essential metabolites that play critical roles in multiple cellular pathways. Like many primary metabolites, mutations that disrupt lipid synthesis can be lethal. Proteins involved in lipid synthesis, trafficking, and modification, are targets for therapeutic intervention in infectious disease and metabolic disorders. The ability to rapidly detect these proteins can accelerate their evaluation as targets for deranged lipid pathologies. However, it remains challenging to identify lipid binding motifs in proteins because the rules that govern protein engagement with specific lipids are poorly understood. As such, new bioinformatic tools that reveal conserved features in lipid binding proteins are necessary. Here, we present Structure-based Lipid-interacting Pocket Predictor (SLiPP), an algorithm that leverages machine learning to detect protein cavities capable of binding to lipids in protein structures. SLiPP uses a Random Forest classifier and operates at scale to predict lipid binding pockets with an accuracy of 96.8% and an F1 score of 86.9% when testing against a set of 8,380 pockets embedded within proteins. Our analyses revealed that the algorithm relies on hydrophobicity-related features to distinguish lipid binding pockets from those that bind to other ligands. SLiPP is fast and does not require substantial computational resources. Use of the algorithm to detect lipid binding proteins in various proteomes produced hits annotated or verified as bona fide lipid binding proteins. Additionally, SLiPP identified many new putative lipid binders in well studied proteomes. Because of its ability to identify novel lipid binding proteins, SLiPP can spur the discovery of new and "targetable" lipid-sensitive pathways.

bioinformatics↗

A cell-permeant nanobody-based degrader that induces fetal hemoglobin

Proximity-based strategies to degrade proteins have enormous therapeutic potential in medicine, but the technologies are limited to proteins for which small molecule ligands exist. The identification of such ligands for therapeutically relevant but "undruggable" proteins remains challenging. Herein, we employed yeast surface display of synthetic nanobodies to identify a protein ligand selective for BCL11A, a critical repressor of fetal globin gene transcription. Fusion of the nanobody to a cell-permeant miniature protein and an E3 adaptor creates a degrader that depletes cellular BCL11A in erythroid precursor cells, thereby inducing the expression of fetal hemoglobin, a modifier of clinical severity of sickle cell disease and {beta}-thalassemia. This work establishes a new paradigm for the targeted degradation of previously intractable proteins using cell-permeant nanobody-based degraders. One sentence summaryA cell-permeant, protein-based degrader is used for the induction of fetal hemoglobin.

biochemistry↗

Structural insights into bacterial sterol transport

Sterol lipids are widely present in eukaryotes and play essential roles in signaling and modulating membrane fluidity. Although rare, some bacteria also produce sterols, but their function in bacteria is not known. Moreover, many more species, including pathogens and commensal microbes, acquire or modify sterols from eukaryotic hosts through poorly understood molecular mechanisms. The aerobic methanotroph Methylococcus capsulatus was the first bacterium shown to synthesize sterols, producing a mixture of C-4 methylated sterols that are distinct from those observed in eukaryotes. C-4 methylated sterols are synthesized in the cytosol and localized to the outer membrane, suggesting that a bacterial sterol transport machinery exists. Until now, the identity of such machinery remained a mystery. In this study, we identified three novel proteins that may be the first examples of transporters for bacterial sterol lipids. The proteins, which all belong to well-studied families of bacterial metabolite transporters, are predicted to reside in the inner membrane, periplasm, and outer membrane of M. capsulatus, and may work as a conduit to move modified sterols to the outer membrane. Quantitative analysis of ligand binding revealed their remarkable specificity for 4-methylsterols, and crystallographic structures coupled with docking and molecular dynamics simulations revealed the structural bases for substrate binding by two of the putative transporters. Their striking structural divergence from eukaryotic sterol transporters signals that they form a distinct sterol transport system within the bacterial domain. Finally, bioinformatics revealed the widespread presence of similar transporters in bacterial genomes, including in some pathogens that use host sterol lipids to construct their cell envelopes. The unique folds of these bacterial sterol binding proteins should now guide the discovery of other proteins that handle this essential metabolite.

biochemistry↗